Eisai Co., Ltd.
Eisai Co., Ltd. (ESALF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ESALF · as of Jun 8, 2026
Key Statistics
Explore Eisai Co., Ltd. Data
esalf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
esalf competitorsESALF
BIOVF
GIFLF
GIFOF
KYKOF
NOBDFStock Performance
Full HistoryAbout Eisai Co., Ltd.
Eisai Co., Ltd. a pharmaceutical company headquartered in Tokyo, Japan, develops and markets a wide array of medicinal products. Its offerings for neurological conditions include Aricept, prescribed …
what is eisai co., ltd. · esalf stock overview · eisai co., ltd. company profile · who is eisai co., ltd. ceo · esalf OTC · eisai co., ltd. headquarters · eisai co., ltd. business segments
About Stock Overview & Key Data
Eisai Co., Ltd. (ESALF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Apr 7, 2011. As of the latest trading session, ESALF stock price is $28.00, with a market capitalization of $7.9B. The stock has returned +1.82% over the past 12 months and -5.82% year-to-date.
In fiscal year 2026, Eisai Co., Ltd. reported revenue of $830.6B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Eisai Co., Ltd. (ESALF) stock price is $28.00. The stock is traded on OTC under the ticker symbol ESALF. The 52-week range is $23.88 – $35.83.